These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31945087)

  • 1. Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    Al-Wajeeh AS; Salhimi SM; Al-Mansoub MA; Khalid IA; Harvey TM; Latiff A; Ismail MN
    PLoS One; 2020; 15(1):e0227404. PubMed ID: 31945087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of protein expression profiles of different stages of lymph nodes metastasis in breast cancer.
    Lee HH; Lim CA; Cheong YT; Singh M; Gam LH
    Int J Biol Sci; 2012; 8(3):353-62. PubMed ID: 22393307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics of Grade 3 infiltrating ductal carcinoma in Malaysian Chinese breast cancer patients.
    Othman MI; Majid MI; Singh M; Subathra S; Seng L; Gam LH
    Biotechnol Appl Biochem; 2009 Mar; 52(Pt 3):209-19. PubMed ID: 18564057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic profiling and interactome analysis of ER-positive/HER2/neu negative invasive ductal carcinoma of the breast: towards proteomics biomarkers.
    Korwar AM; Bhonsle HS; Ghole VS; Gawai KR; Koppikar CB; Kulkarni MJ
    OMICS; 2013 Jan; 17(1):27-40. PubMed ID: 23301641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.
    Davalieva K; Kiprijanovska S; Broussard C; Petrusevska G; Efremov GD
    Mol Biol (Mosk); 2012; 46(3):469-80. PubMed ID: 22888636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
    Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
    BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [2-DE profiling and differential analysis of human bronchial epithelial tissues in different stages of carcinogenesis].
    Wu XY; Li C; Xiao ZQ; Li JL; Feng XP; Yi H; Li MY; Chen ZC
    Ai Zheng; 2004 May; 23(5):522-30. PubMed ID: 15142447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics analysis of human breast milk by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) coupled with mass spectrometry to assess breast cancer risk.
    Aslebagh R; Whitham D; Channaveerappa D; Lowe J; Pentecost BT; Arcaro KF; Darie CC
    Electrophoresis; 2023 Jul; 44(13-14):1097-1113. PubMed ID: 36971330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Profiling of Invasive Ductal Carcinoma (IDC) using Magnetic Beads-based Serum Fractionation and MALDI-TOF MS.
    Yang J; Zhu J; He K; Zhao LY; Liu LY; Song TS; Huang C
    J Clin Lab Anal; 2015 Jul; 29(4):321-7. PubMed ID: 25130542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS.
    Song MN; Moon PG; Lee JE; Na M; Kang W; Chae YS; Park JY; Park H; Baek MC
    Arch Pharm Res; 2012 Oct; 35(10):1839-47. PubMed ID: 23139137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
    Milioli HH; Santos Sousa K; Kaviski R; Dos Santos Oliveira NC; De Andrade Urban C; De Lima RS; Cavalli IJ; De Souza Fonseca Ribeiro EM
    Cancer Genomics Proteomics; 2015; 12(2):89-101. PubMed ID: 25770193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast.
    Somiari RI; Sullivan A; Russell S; Somiari S; Hu H; Jordan R; George A; Katenhusen R; Buchowiecka A; Arciero C; Brzeski H; Hooke J; Shriver C
    Proteomics; 2003 Oct; 3(10):1863-73. PubMed ID: 14625848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
    Schaub NP; Jones KJ; Nyalwidhe JO; Cazares LH; Karbassi ID; Semmes OJ; Feliberti EC; Perry RR; Drake RR
    J Am Coll Surg; 2009 May; 208(5):970-8; discussion 978-80. PubMed ID: 19476873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues.
    Othman MI; Majid MI; Singh M; Man CN; Lay-Harn G
    Ann Clin Biochem; 2008 May; 45(Pt 3):299-306. PubMed ID: 18482919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of pathway biomarkers from coupled proteomics and systems biology methods.
    Zhang F; Chen JY
    BMC Genomics; 2010 Nov; 11 Suppl 2(Suppl 2):S12. PubMed ID: 21047379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.
    Hu X; Zhang Y; Zhang A; Li Y; Zhu Z; Shao Z; Zeng R; Xu LX
    OMICS; 2009 Aug; 13(4):291-300. PubMed ID: 19624269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.
    Gomig THB; Cavalli IJ; Souza RLR; Vieira E; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; de Andrade Urban C; Cavalli LR; Ribeiro EMSF
    J Proteomics; 2019 May; 199():1-14. PubMed ID: 30772490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.